FDA revises and expands draft guidance on adjusting for covariates in RCTs
The FDA on Thursday revised and expanded a 2019 draft guidance that spells out how to adjust for covariates in the statistical analysis of randomized …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
